That statement also ignores the implications of actually having Remestemcel-L on the market - Label Expansions, Off-Label Use and the FDA guided steps to COVID ARDS EUA.
Looking at only the market of one indication is a very narrow-minded view. It's like saying Amazon is at a 52-Week Low so they must have failed as a company.
MSB $1 Party, page-432
-
- There are more pages in this discussion • 717 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.8¢ |
Change
0.053(5.93%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $3.171M | 3.451M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 19818 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 83994 | 10 |
View Market Depth
| Last trade - 12.30pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |